Alpha Teknova (TKNO) Operating Leases (2022 - 2026)
Alpha Teknova's (TKNO) quarterly Operating Leases came in at $12.7 million in Q1 2026, down 12.16% year-on-year from $14.5 million in Q1 2025, and down 3.98% on a QoQ basis from $13.3 million in Q4 2025.
Alpha Teknova (TKNO) Operating Leases (2022 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 5 years of Operating Leases data on file, last reported at $12.7 million in Q1 2026.
- On a quarterly basis, Operating Leases fell 12.16% year-over-year to $12.7 million in Q1 2026; TTM through Mar 2026 was $12.7 million, a 12.16% decrease from a year earlier, with the FY2025 full-year figure at $13.3 million, down 10.84% from the prior year.
- Operating Leases for Q1 2026 stood at $12.7 million, down from $13.3 million in the prior quarter.
- Over the last five years, Operating Leases for TKNO reached as high as $18.1 million in Q4 2022 and fell as low as $12.7 million in Q1 2026.
- Historically, Operating Leases has averaged $15.6 million across 5 years, with a median of $15.8 million in 2024.
- Across the five-year window, Operating Leases fell 14.95% in 2023 and dropped 3.12% in 2024, its largest moves.
- Year by year, Operating Leases stood at $18.1 million in 2022, then decreased by 14.95% to $15.4 million in 2023, then retreated by 3.38% to $14.9 million in 2024, then declined by 10.84% to $13.3 million in 2025, then dropped by 3.98% to $12.7 million in 2026.
- Per Business Quant data, the three most recent Operating Leases figures were $12.7 million in Q1 2026, $13.3 million in Q4 2025, and $14.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.74 Mn |
| Dec 31, 2025 | 13.27 Mn |
| Sep 30, 2025 | 14.02 Mn |
| Jun 30, 2025 | 14.05 Mn |
| Mar 31, 2025 | 14.51 Mn |
| Dec 31, 2024 | 14.88 Mn |
| Sep 30, 2024 | 15.36 Mn |
| Jun 30, 2024 | 15.81 Mn |
| Mar 31, 2024 | 16.26 Mn |
| Dec 31, 2023 | 15.40 Mn |
| Sep 30, 2023 | 15.87 Mn |
| Jun 30, 2023 | 16.32 Mn |
| Mar 31, 2023 | 16.87 Mn |
| Dec 31, 2022 | 18.11 Mn |
| Sep 30, 2022 | 16.83 Mn |
| Jun 30, 2022 | 17.41 Mn |
| Mar 31, 2022 | 17.94 Mn |